Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850939 · ClinicalTrials.gov registry record · NA
Improving Adherence to EHT Among Breast Cancer Patients
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT02850939 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 108 participants.
The verdict
NCT02850939, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast cancer patients with hormone receptor-positive tumors, which represent 75% of all breast cancer diagnoses. Long-term use of EHT reduces cancer recurrence rates and cuts the risk of death nearly in half during the second decade after diagnosis, research shows. Despite the proven benefits, about 33% of women who are prescribed EHT do not take their medication as prescribed (less than 80% take their daily dosage) and are thus at higher risk of recurrence and death. This educational randomized controlled study will develop and pilot-test a bilingual, culturally tailored, personalized, interactive mobile application (app) in combination with patient navigation to promote and improve adherence to endocrine hormonal therapy (EHT) among breast cancer patients.
Interventions
- BEHAVIORAL Mobile phone app + patient navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02850939
The ClinicalTrials.gov registry entry for NCT02850939 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile phone app + patient navigation is the first listed.
NCT02850939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02850939 about?
NCT02850939 is a clinical study titled "Improving Adherence to EHT Among Breast Cancer Patients". Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast cancer patients with hormone receptor-positive tumors, which represent 75% of all breast cancer diagnoses. Long-term use of EHT reduces cancer recurrence rates and cuts the risk of death nearly in hal...
What is the current status of trial NCT02850939?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2021-05-03. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT02850939?
The interventions under investigation include: Mobile phone app + patient navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02850939?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.